Although clinical trials specifically for MASH have not yet been conducted, preclinical studies confirm significant regulatory effects on hepatic metabolism, providing a novel strategy for targeted MASH therapy and supporting future translational research
GHK-Cu (Pickart & Margolina, 2018): Activates 4,000+ genes for tissue remodeling, collagen synthesis, and stem cell recruitment
With our tailored approach, youll receive ongoing guidance from board-certified professionals, ensuring safe and effective treatment at every step
Peptides, or small protein fragments, are often too unstable to use as drugs, but in this study, the researchers also developed a way to stabilize the molecules and help them get into target cells